Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship-Reference-Cited by-同舟云学术

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Published:2008-05 Issue:5 Volume:83 Page:584-594
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Molina Julian R.,Yang Ping,Cassivi Stephen D.,Schild Steven E.,Adjei Alex A.

Publisher

Elsevier BV

Subject

General Medicine

Reference114 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Temporal trends in small cell lung cancer: analysis of the national Surveillance Epidemiology and End-Results (SEER) database [abstract 7082];Navada;J Clin Oncol,2006

3. Small cell lung cancer;Sher;Mayo Clin Proc,2008

4. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003;Yang;Chest,2005

5. The impact of tobacco on lung health in China;Zhang;Respirology,2003

Cited by 1947 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disulfiram/copper complex improves the effectiveness of the WEE1 inhibitor Adavosertib in p53 deficient non-small cell lung cancer via ferroptosis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

2. Pan-cancer analysis and experimental validation reveal FAM72D as a potential novel biomarker and therapeutic target in lung adenocarcinoma;Gene;2024-11

3. MIG6 loss increased RET inhibitor tolerant persister cells in RET-rearranged non-small cell lung cancer;Cancer Letters;2024-11

4. Prospective study of dual-phase 99mTc-MIBI SPECT/CT nomogram for differentiating non-small cell lung cancer from benign pulmonary lesions;European Journal of Radiology;2024-10

5. Structural Perspectives in the Development of Novel EGFR Inhibitors for the Treatment of NSCLC;Mini-Reviews in Medicinal Chemistry;2024-10